Covance Clinical Research Associate II / Senior CRA - Scotland in Maidenhead, United Kingdom
Covance are currently recruiting for a CRA II or Senior CRA in Scotland to work on Oncology trials but also Vaccines, Hepatitis and HIV studies. Although technically a national monitoring role, we try very hard to align our CRAs geographically and so the majority of sites will be in Scotland and the north of England.
What makes this opportunity special?
You will be 100% client focused with a prestigious Pharmaceutical company.
Career progression will be exceptional because there are lots of studies coming through in 2018 across a variety of therapeutic areas
Unlike some CRA roles you will not be pushed to satisfy unrealistic ‘monthly visit’ targets (average of 8 per month)
The job is permanent and full time
Your Line Manager will also be based in Scotland and so there will be regular meets if need be
You will be joining a big team with a well organised structure and robust processes in place.
As an experienced CRA (with at least 1.5 years of monitoring) you’ll be involved in initiation, routine & close out visits. Successful candidates will enjoy the benefits of working for a company that values a WORK / LIFE BALANCE.
Other Information: This role is a full time & permanent position to be employed through Covance. For more information please contact Andy Smith at Covance on 07775 848 250 or mail
Key words: Clinical Research, SCRA, Clinical Research Associate, Scotland GCP, Monitor, Monitoring, Senior Clinical Research Associate, CRA I, Oncology, Field Based, Home Based, CRO, Pharmaceutical, Scotland, Edinburgh, CRA, Glasgow, central belt
Education / Qualifications
BSc Preferred but not essential
Previous Oncology experience preferred but not essential
Job Number 2017-16120
Job Category Clinical Research Associate
Position Type Full-Time
Covance is committed to diversity in the workplace and is an equal opportunity employer (Minority/Female/Individual with Disability/Veteran/Sexual Orientation/Gender Identity). Your confidentiality and privacy are important to us.